Načítá se...
COVID-19 prevalence and outcomes in patients receiving biologic therapies at an infusion center in New York City
To better understand COVID-19 infection in patients receiving biologic and immunomodulatory therapies, we evaluated prevalence and outcomes for symptomatic cases of COVID-19 at a large therapeutic infusion center in New York City during the height of the pandemic. 2074 patients received treatment wi...
Uloženo v:
| Vydáno v: | Clin Immunol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier Inc.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8294696/ https://ncbi.nlm.nih.gov/pubmed/34302970 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clim.2021.108803 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|